324 related articles for article (PubMed ID: 26083546)
1. Clinical Impact of Rapid Reduction of Low-Density Lipoprotein Cholesterol Level on Long-Term Outcome of Acute Myocardial Infarction in the Statin Era: Subanalysis of the ALPS-AMI Study.
Miura T; Izawa A; Motoki H; Miyashita Y; Kashima Y; Ebisawa S; Tomita T; Koyama J; Ikeda U
PLoS One; 2015; 10(6):e0127835. PubMed ID: 26083546
[TBL] [Abstract][Full Text] [Related]
2. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS).
Ota T; Ishii H; Suzuki S; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Tanaka A; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
Atherosclerosis; 2015 Sep; 242(1):155-60. PubMed ID: 26188539
[TBL] [Abstract][Full Text] [Related]
3. Relationship between low-density lipoprotein levels on admission and 1-year outcome in patients with acute ST-segment-elevation myocardial infarction.
Sun YJ; Li YZ; Jiang DM; Zhang B; Gao Y; Zhang ZH; Qi GX
Kaohsiung J Med Sci; 2013 Apr; 29(4):206-13. PubMed ID: 23541266
[TBL] [Abstract][Full Text] [Related]
4. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.
Piao ZH; Jin L; Kim JH; Ahn Y; Kim YJ; Cho MC; Kim CJ; Kim HS; Liu B; Jeong MH;
Am J Cardiol; 2017 Jul; 120(2):174-180. PubMed ID: 28532771
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥ 50% reduction from baseline versus <70 mg/dL.
Cho KH; Jeong MH; Park KW; Kim HS; Lee SR; Chae JK; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC;
Int J Cardiol; 2015; 187():478-85. PubMed ID: 25846658
[TBL] [Abstract][Full Text] [Related]
6. Relation between paradoxical decrease in high-density lipoprotein cholesterol levels after statin therapy and adverse cardiovascular events in patients with acute myocardial infarction.
Ota T; Ishii H; Suzuki S; Tanaka A; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
Am J Cardiol; 2015 Feb; 115(4):411-6. PubMed ID: 25555656
[TBL] [Abstract][Full Text] [Related]
7. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol.
Lee KH; Jeong MH; Kim HM; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
J Am Coll Cardiol; 2011 Oct; 58(16):1664-71. PubMed ID: 21982310
[TBL] [Abstract][Full Text] [Related]
8. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
[TBL] [Abstract][Full Text] [Related]
9. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
10. Effect of Statin Treatment and Low-Density Lipoprotein-Cholesterol on Short-Term Mortality in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention - Multicenter Registry From Tokyo CCU Network Database.
Miura M; Yamasaki M; Uemura Y; Yoshikawa M; Miyauchi K; Tanaka H; Miyachi H; Yamashita J; Suzuki M; Yamamoto T; Nagao K; Komuro I; Takayama M
Circ J; 2016; 80(2):461-8. PubMed ID: 26658282
[TBL] [Abstract][Full Text] [Related]
11. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention.
Oduncu V; Erkol A; Kurt M; Tanboğa IH; Karabay CY; Şengül C; Bulut M; Özveren O; Fotbolcu H; Akgün T; Türkyilmaz E; Kırma C
Int J Cardiol; 2013 Jul; 167(2):458-63. PubMed ID: 22305817
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein levels and outcomes after statin therapy.
Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E;
N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study.
Kashima Y; Izawa A; Aizawa K; Koshikawa M; Kasai H; Tomita T; Kumazaki S; Tsutsui H; Koyama J; Ikeda U
J Cardiol; 2009 Aug; 54(1):76-9. PubMed ID: 19632524
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox).
Cho KH; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Seung KB; Park SJ;
Am J Cardiol; 2010 Oct; 106(8):1061-8. PubMed ID: 20920639
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and efficacy of Pitavastatin in patients with acute myocardial infarction (from the Livalo Acute Myocardial Infarction Study [LAMIS]).
Suh SY; Rha SW; Ahn TH; Shin EK; Choi CU; Oh DJ; Bae JH; Hur SH; Yun KH; Oh SK; Kim JH; Kim SW; Chae IH; Kim KS; Hong YJ; Jeong MH;
Am J Cardiol; 2011 Dec; 108(11):1530-5. PubMed ID: 21890083
[TBL] [Abstract][Full Text] [Related]
17. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
19. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates.
Baessler A; Fischer M; Huf V; Mell S; Hengstenberg C; Mayer B; Holmer S; Riegger G; Schunkert H
Int J Cardiol; 2005 May; 101(2):293-8. PubMed ID: 15882678
[TBL] [Abstract][Full Text] [Related]
20. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
Davidson MH; Donovan JM; Misir S; Jones MR
Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
